You Might Want to Wait to Get a Booster Shot
After a long and tense meeting today, an FDA committee unanimously recommended that the agency authorize third shots of the Pfizer COVID-19 vaccine for Americans who are over 65 or at high risk of severe COVID. The vote came after the panel voted overwhelmingly against the original question up for its consideration: authorizing boosters for everyone over 16. If the FDA follows the committee’s recommendation (as is expected), a CDC committee will help refine those guidelines next week, clarifying which groups qualify as “high risk.”
Even as we await these final decisions, the nation’s summer wave of COVID infections seems like it’s beginning to pass. Cases and hospitalizations are trending slightly downward. Now that we have (and ) Americans need booster shots—and given that so many people are , eligibility be damned—more questions loom: , exactly, should those people get those shots? Is it better to load up on extra antibodies as soon as possible, or should people wait until COVID rates start to rise again?
You’re reading a preview, subscribe to read more.
Start your free 30 days